Sialic acid-modified nanomedicines modulate neutrophils for dual therapy of cancer and sepsis: addressing neglected sepsis comorbidities during cancer treatmentYantong Li, Yihui Deng, Tingyan Liu et al.|International Journal of Pharmaceutics|2025Cited by 5
Targeting GFPT2 to reinvigorate immunotherapy in EGFR-mutated NSCLCLuyao Ao, Jiali Liu, Wenjing Jia et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2
GFPT2 controls immune evasion in EGFR-mutated non-small cell lung cancerJiali Liu, Fang Zhou, Luyao Ao et al.|Research Square|2024Cited by 1